Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [15581]

FDA approves niraparib and abiraterone acetate plus prednisone for BRCA2-mutated metastatic castration-sensitive prostate cancer

FDA approves niraparib and abiraterone acetate plus prednisone for BRCA2-mutated metastatic castration-sensitive...

Targeting B-cells may boost immunotherapy in liver cancer treatment

Targeting B-cells may boost immunotherapy in liver cancer treatment

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new treatments

World-first discovery uncovers how glioblastoma tumours dodge chemotherapy, potentially opening the door to new...

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity via ERCC1 isoform switching

Genome-wide CRISPR-Cas9 screening identifies CLK1 inhibition as a strategy to restore PARP inhibitor sensitivity...

Dual-function biomaterials for postoperative osteosarcoma: Tumour suppression and bone regeneration

Dual-function biomaterials for postoperative osteosarcoma: Tumour suppression and bone regeneration

Scientists use ultrasound to soften and treat cancer tumors without damaging healthy tissue

Scientists use ultrasound to soften and treat cancer tumors without damaging healthy tissue

This new understanding of T cell receptors may improve cancer immunotherapies

This new understanding of T cell receptors may improve cancer immunotherapies

A new immunotherapy approach could work for many types of cancer

A new immunotherapy approach could work for many types of cancer

Alcohol causes cancer. A study confirms damage to DNA and shows how cells defend against it

Alcohol causes cancer. A study confirms damage to DNA and shows how cells defend against it

Researchers solve a key colorectal cancer mystery

Researchers solve a key colorectal cancer mystery

More from ecancer